The Business of Baby Factories: How Wealth and Science Mix

A Chinese tech boss is skipping traditional succession planning entirely. Instead of trusting boards or mentoring employees, he’s betting on biology. By paying American women to carry designer babies, he aims to produce an heir with pre-selected traits—like ordering custom products from a menu. This isn’t about growing a family; it’s about growing corporate legacy on demand. Surrogacy laws in the U. S. have become an easy loophole for global elites. While many couples use surrogacy for personal joy, the system gets hijacked when money trumps ethics. Babies become inventory, ranked by potential, rather than embraced as individuals. And the problems don’t stop at the boardroom. Traffickers have turned fertility services into a pipeline, exploiting women and trafficking newborns across state lines.Genetic engineering has moved from fiction to lab reality. In 2019, a Chinese scientist crossed a line by altering human embryos using CRISPR, sparking global outrage and legal consequences. Now, fertility clinics don’t just match traits—they rank embryos by predicted IQ, health, and even behavior. Want a future CEO? Pay to screen out the rest. This isn’t just parenting—it’s shopping for traits. Surrogacy and gene editing reveal a troubling shift in values. Children aren’t seen as gifts; they’re products to be optimized. This mirrors dystopian ideas—where human life has grades, and only the “best” get a future. The irony? The same people pushing these technologies often fund both the science and the systems that exploit them. As labs refine embryo selection and surrogacy becomes a global trade, one question lingers: What happens when society values potential over personhood?